About Isologic

This author has not yet filled in any details.
So far Isologic has created 9 blog entries.

Product Update: I-131 Dx capsule supply

2019-01-11T16:07:52-04:00January 11th, 2019|

PRODUCT UPDATE - January 10th, 2019 MONTREAL, January 10th, 2019 Dear Customer, We would like to inform you of our I-131 Dx capsule supply. We will have 100 μCi diagnostic capsules available on January 21st. These capsules will have a calibration date of January 23rd.  We also have [...]

Product Update

2018-12-24T11:27:37-04:00December 24th, 2018|

PRODUCT UPDATE - DECEMBER 20th, 2018 MONTREAL, DEC. 20th, 2018 Dear Customer, We would like to inform you that due to an unforeseeable I-131 Dx capsule production issue we will not be able to produce and ship I-131 Dx capsule for an undetermined period of time. We have [...]

First diagnostic radiotracer for early diagnosis of Alzheimer’s disease approved in Canada

2018-04-05T16:12:04-04:00March 1st, 2018|

PIRAMAL IMAGING SA AND ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ANNOUNCE COMMERCIAL APPROVAL OF NEURACEQ™ BY HEALTH CANADA MONTREAL, Feb. 28, 2017 /CNW Telbec Piramal Imaging SA and ISOLOGIC Innovative Radiopharmaceuticals today announce that Health Canada has issued a Notice of Compliance (NOC) to ISOLOGIC Innovative Radiopharmaceuticals for NeuraCeq (florbetaben [...]

IRE-ELiT S.A. & Isologic Sign Exclusive Agreement

2018-04-05T16:11:22-04:00January 31st, 2018|

IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic signed an exclusive agreement for the distribution of Galli Eo™ 68Ge/ 68Ga generator in Canada FLEURUS, Belgium ; Montreal, Canada ; the 31st January. IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic Innovative Radiopharmaceuticals, the Canadian leader in radiopharmacy servicess announced [...]

ISOLOGIC Acquires Lantheus Canadian Imaging Centres

2018-05-01T21:31:40-04:00January 14th, 2016|

ISOLOGIC Acquires Lantheus Canadian Imaging Centres ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ACQUIRES LANTHEUS MEDICAL IMAGING CANADIAN RADIOPHARMACEUTICAL CENTRES ISOLOGIC is pleased to announce the completion of an asset purchase agreement for the acquisition of the Canadian radiopharmacy and Gludef manufacturing and distribution business operations of Lantheus Medical [...]

Toronto Area Better Equipped

2018-04-05T16:13:37-04:00July 7th, 2015|

GREATER TORONTO AREA BETTER EQUIPPED TO PRODUCE RADIOPHARMACEUTICAL COMPONENTS USED IN CANCER, CARDIAC AND ALZHEIMER’S DETECTION A new cyclotron and radiopharmaceutical manufacturing facility, opened by ISOLOGIC Innovative Radiopharmaceuticals Ltd. (ISOLOGIC) at Toronto’s Sunnybrook Health Sciences Centre, is expanding access to positron emitting radiopharmaceuticals (PERs), an essential [...]

Piramal Announces Strategic Partnership with ISOLOGIC

2018-04-05T16:14:07-04:00June 4th, 2015|

PIRAMAL IMAGING ANNOUNCES STRATEGIC PARTNERSHIP WITH ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS FOR EXCLUSIVE COMMERCIALIZATION OF NEURACEQ IN CANADA BOSTON, June 4, 2015 Piramal Imaging SA and ISOLOGIC Innovative Radiopharmaceuticals today announce the companies have entered into a strategic partnership and licensing agreement to provide ISOLOGIC with exclusive [...]

Canadian Radiopharmacy Acquisitions

2018-04-05T16:14:33-04:00March 24th, 2014|

PHARMALOGIC P.E.T. SERVICES OF MONTREAL COMPANY AND CARDINAL HEALTH CANADIAN RADIOPHARMACY ACQUISITIONS March 24th, 2014 IsoLogic is proud to announce that following the acquisitions of Pharmalogic P.E.T. Services of Montreal and Cardinal Health’s Ontario based radiopharmacies, it will operate the combined businesses as IsoLogic Innovative Radiopharmaceuticals going forward. [...]